We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.79B
AUM Growth
-$19.8M
Cap. Flow
-$506M
Cap. Flow %
-7.46%
Top 10 Hldgs %
64.12%
Holding
139
New
17
Increased
28
Reduced
77
Closed
11

Top Buys

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$17M
2
JNJ icon
Johnson & Johnson
JNJ
+$12.1M
3
SHPG
Shire pic
SHPG
+$8.78M
4
AGN
Allergan plc
AGN
+$5.04M
5
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$2.88M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$41.2M
2
HDB icon
HDFC Bank
HDB
+$38.7M
3
UNP icon
Union Pacific
UNP
+$29.7M
4
MSFT icon
Microsoft
MSFT
+$28.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 34.47%
2 Healthcare 19.26%
3 Communication Services 16.08%
4 Consumer Discretionary 11.63%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
76
Teva Pharmaceuticals
TEVA
$39.9B
$2.07M 0.03%
36,000
– –
NPSP
77
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.75M 0.03%
+48,947
New +$1.46M
REGN icon
78
Regeneron Pharmaceuticals
REGN
$73.2B
$1.48M 0.02%
3,600
-450
-11% -$177K
EGRX
79
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.46M 0.02%
94,407
-45,593
-33% -$582K
INNL
80
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$1.46M 0.02%
245,184
+120,184
+96% +$836K
OXFD
81
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.37M 0.02%
100,460
+40,460
+67% +$553K
RPRX
82
DELISTED
Repros Therapeutics Inc.
RPRX
$1.35M 0.02%
+135,000
New +$1.15M
ATEC icon
83
Alphatec Holdings
ATEC
$1.45B
$1.25M 0.02%
74,052
-35,763
-33% -$609K
AEGR
84
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.17M 0.02%
55,940
+10,940
+24% +$276K
HNT
85
DELISTED
HEALTH NET INC
HNT
$1.12M 0.02%
20,977
-59,023
-74% -$2.91M
SUPN icon
86
Supernus Pharmaceuticals
SUPN
$2.74B
$1.08M 0.02%
+130,000
New +$1.09M
PTLA
87
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.05M 0.02%
37,013
-15,919
-30% -$443K
ASXC
88
DELISTED
Asensus Surgical, Inc.
ASXC
$981K 0.01%
25,936
-12,526
-33% -$517K
CARM
89
DELISTED
Carisma Therapeutics
CARM
$801K 0.01%
3,372
-1,628
-33% -$365K
CRDF icon
90
Cardiff Oncology
CRDF
$60.7M
$725K 0.01%
2,341
-1,131
-33% -$366K
ACOR
91
DELISTED
Acorda Therapeutics
ACOR
$654K 0.01%
+133
New +$571K
ALXA
92
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$596K 0.01%
400,273
-315,307
-44% -$563K
INVA icon
93
Innoviva
INVA
$1.6B
$594K 0.01%
41,955
-34,545
-45% -$519K
DVAX
94
DELISTED
Dynavax Technologies
DVAX
$589K 0.01%
+34,962
New +$532K
LMNS
95
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$526K 0.01%
56,362
-24,242
-30% -$229K
XLRN
96
DELISTED
Acceleron Pharma
XLRN
$409K 0.01%
10,500
– –
TD icon
97
Toronto Dominion Bank
TD
$195B
$406K 0.01%
7,320
+5,570
+318% +$269K
BCE icon
98
BCE
BCE
$20.5B
$404K 0.01%
7,580
+1,280
+20% +$57.5K
SCI icon
99
Service Corp International
SCI
$11.7B
$402K 0.01%
17,700
+5,200
+42% +$114K
STML
100
DELISTED
Stemline Therapeutics, Inc.
STML
$364K 0.01%
21,350
– –
2 3
4
5 6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2014 Portfolio in Review

As of Q4 2014, C WorldWide Group held 139 positions worth $6.79B, down 0.29% from $6.81B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

C WorldWide Group withdrew a net $506M in Q4 2014, closing 11 positions and reducing 77 holdings. Its most notable exit was AUXILIUM PHARAMCEUTICALS INC, an estimated $8.32M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, C WorldWide Group opened a new position in AUSPEX PHARMACEUTICALS INC COM STK (DE) worth $5.14M.

  • C WorldWide Group's largest Q4 2014 buy was AUSPEX PHARMACEUTICALS INC COM STK (DE): 97,921 shares worth $5.14M.
  • C WorldWide Group added most to SALIX PHARMACEUTICALS LTD DEL in Q4 2014, an estimated $17M increase.
  • C WorldWide Group's biggest Q4 2014 reduction was Visa, cutting an estimated $41.2M.
  • C WorldWide Group fully exited AUXILIUM PHARAMCEUTICALS INC in Q4 2014, selling an estimated $8.32M.
  • C WorldWide Group's ten largest holdings make up 64% of its $6.79B portfolio in Q4 2014.
  • C WorldWide Group opened 17 new positions and closed 11 in Q4 2014.
  • C WorldWide Group's portfolio value fell 0.29% quarter-over-quarter to $6.79B.

Based on C WorldWide Group's 13F filing for Q4 2014, filed 11 Feb 2015.